Sanofi sees promise in a pill for inflammatory conditions | Drug Discovery News

Sanofi sees promise in a pill for inflammatory conditions | Drug Discovery News: Elizabeth Laws leads Sanofi’s inflammation and immunology development pipeline to test the first oral TNFR1 inhibitor for rheumatoid arthritis and psoriasis.